For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

B-Cell Disorders and Curcumin.

TitleB-Cell Disorders and Curcumin.
Publication TypeJournal Article
Year of Publication2017
AuthorsGolombick T, Diamond TH, Manoharan A, Ramakrishna R
JournalIntegr Cancer Ther
Volume16
Issue3
Pagination255-257
Date Published2017 09
ISSN1552-695X
KeywordsB-Lymphocytes, Curcuma, Curcumin, Disease Progression, Hematologic Diseases, Humans
Abstract

Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.

DOI10.1177/1534735415622013
Alternate JournalIntegr Cancer Ther
PubMed ID26674787
PubMed Central IDPMC5759937